TYRP2-mediated resistance to cis-diamminedichloroplatinum (II) in human melanoma cells is independent of tyrosinase and TYRP1 expression and melanin content

Tyrosinase-related protein-2 (TYRP2) is a melanocyte-specific enzyme that catalyses the non-decarboxylative tautomerization of l-dopachrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA) in the melanin biosynthetic pathway. We have recently demonstrated that the constitutive expression of TYRP2 in human melanoma cells positively correlates with cis-diamminedichloroplatinum (II) (CDDP) resistance, and that the ectopic expression of TYRP2 in CDDP-sensitive cells rendered them more resistant to CDDP treatment. Here, we demonstrate that this correlation between constitutive TYRP2 expression and CDDP resistance applies to a panel of distinct human melanoma cell lines obtained from patients with melanoma at various stages of disease progression. We further show that CDDP resistance correlates only with TYRP2 expression and is associated neither with tyrosinase and TYRP1 expression, nor with cellular melanin content. Together, these results further support the notion that TYRP2 is a novel mediator of CDDP resistance in melanoma cells and suggest that this function of TYRP2 is independent of cellular melanin content and of the other regulatory enzymes of the melanogenic pathway.

[1]  B. Pak,et al.  Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications , 2000, Oncogene.

[2]  西岡 恵里 Expression of tyrosinase, TRP-1 and TRP-2 in ultravioletirradiated human melanomas and melanocytes : TRP-2 protects melanoma cells from ultraviolet B induced apoptosis , 2000 .

[3]  W. Hiddemann,et al.  Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[4]  J. Westwick,et al.  Cytokine-induced Apoptosis in Epithelial HT-29 Cells Is Independent of Nitric Oxide Formation , 1999, The Journal of Biological Chemistry.

[5]  K. Jimbow,et al.  Tyrosinase transfection produces melanin synthesis and growth retardation in glioma cells , 1998, Melanoma research.

[6]  M. d’Ischia,et al.  Nitric oxide-induced oxidation of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid under aerobic conditions: non-enzymatic route to melanin pigments of potential relevance to skin (photo)protection. , 1998, Biochimica et biophysica acta.

[7]  S. Gupta,et al.  Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. , 1998, Cancer research.

[8]  H. Miyake,et al.  Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer , 1998, Oncogene.

[9]  C. Leonetti,et al.  c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. , 1998, Cancer Research.

[10]  C. A. Ramsden,et al.  Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.

[11]  A. Napolitano,et al.  Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation. , 1997, Biochimica et biophysica acta.

[12]  Y. Vodovotz,et al.  Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. , 1997, Nitric oxide : biology and chemistry.

[13]  F. D’Acquisto,et al.  5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. , 1995, Life sciences.

[14]  K. Jimbow,et al.  Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R , 1995, Melanoma research.

[15]  C. Corsaro,et al.  Melanins in physiological conditions protect against lipoperoxidation. A study on albino and pigmented Xenopus. , 1995, Pigment cell research.

[16]  J. Wolchok,et al.  Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation. , 1995, The Journal of investigative dermatology.

[17]  R. Kerbel,et al.  Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance. , 1995, Cancer research.

[18]  K. Urabe,et al.  A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.

[19]  M. S. Yates,et al.  The Protective Effect of Glycine in Cisplatin Nephrotoxicity: Inhibition with NG‐Nitro‐l‐arginine Methyl Ester , 1994, The Journal of pharmacy and pharmacology.

[20]  G. Chu,et al.  Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. , 1994, The Journal of biological chemistry.

[21]  J. Mordoh,et al.  Role of melanin as a scavenger of active oxygen species. , 1993, Pigment cell research.

[22]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[23]  P. O'Connor,et al.  Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines , 1992, Molecular and cellular biology.

[24]  N. Copeland,et al.  A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus. , 1992, The EMBO journal.

[25]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  F. Solano,et al.  Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase. , 1990, Biochimica et biophysica acta.

[27]  G. Chu,et al.  Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Ozols,et al.  Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. , 1988, Biochemical pharmacology.

[29]  S. Howell,et al.  Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. , 1985, Cancer research.

[30]  T. Ishikawa,et al.  Photoprotective role of epidermal melanin granules against ultraviolet damage and DNA repair in guinea pig skin. , 1984, Cancer research.